News

Medical marijuana legalization not tied to uptick in teen use


 

FROM THE LANCET PSYCHIATRY

References

Marijuana use was higher in states that legalized treatment of medical conditions with marijuana, but the increased use was present both before and after such laws were passed, according to annual, repeated cross-sectional surveys.

“[T]he overall effect of medical marijuana laws on adolescent use before versus after passage of the law remained nonsignificant, although (as for the overall results), use was significantly reduced in 8th- but not for 10th- or 12th-graders,” noted Dr. Deborah S. Hasin, professor of epidemiology (in psychiatry) at Columbia University Medical Center, New York, and her colleagues.

©ron hilton/iStockphoto.com

The findings were based on responses to surveys from 1,098,270 students in the 8th, 10th, and 12th grades between 1991 and 2014. Respondents were from the 48 contiguous states, 21 of which had passed medical marijuana laws by 2014. Mean response rates for 1991-2013 were 81%-91% for almost all years and grades.

Students were asked if they had used marijuana in the previous 30 days; 15.87% of them said they had, in states that had passed a medical marijuana law between 1991 and 2014. In states that had not passed that type of a law, the prevalence of marijuana use was 13.27%.

The study showed no evidence for an increase in adolescent use of marijuana in the year of passage of a medical marijuana law, or in the first or second years after passage.

Prior to passage of a law permitting the use of marijuana for medicinal purposes, 16.25% of the survey’s participants said they had used marijuana within the previous 30 days. Following such legislative changes, the prevalence of use was 15.45%.

“Our two main findings, in conjunction with other evidence, suggest that state-level factors other than medical marijuana laws influence adolescent marijuana use,” the researchers wrote.

Dr. Hasin and her colleagues declared no conflicts of interest.

Read the full study here.

klennon@frontlinemedcom.com

Recommended Reading

VIDEO: Cannabis further compromises cognitive function in some MS patients
MDedge Psychiatry
IHC: In medication overuse headache, think ‘stress reduction’
MDedge Psychiatry
Many people with alcohol use disorder not getting treatment
MDedge Psychiatry
APA: Initial response to buprenorphine-naloxone predicts effectiveness at 12 weeks
MDedge Psychiatry
APA: Screen all patients for substance abuse
MDedge Psychiatry
VIDEO: Screening for substance use disorders is essential
MDedge Psychiatry
ICOO: Massachusetts governor takes on opioid epidemic
MDedge Psychiatry
Poison center calls for fake pot up 330% in first half of 2015
MDedge Psychiatry
‘Dabbing’ on the rise: Is this marijuana use dangerous?
MDedge Psychiatry
ICOO: Quality metrics needed for medical marijuana
MDedge Psychiatry